This has happened with some transactions.
e.g. Synthorx bought early Phase 1 in 2019 by Sanofi.
https://www.sanofi.com/en/media-room/press-releases/2019/2019-12-09-06-00-00-1957603
Sanofi have now put that program on back burner in Phase 2 ( efficacy not meeting expectations ).
https://www.biopharmadive.com/news/sanofi-synthorx-il2-cancer-drug-delay/635206/
Ann: Race Leadership Changes, page-338
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
0.010(0.65%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.56 | $1.51 | $95.69K | 62.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3015 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 4018 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |